Latest News

Combating COVID-19

By March 25, 2021 No Comments
We are a year into the global pandemic, and many Cerrell clients have been working tirelessly over the past 12 months to support patients, develop COVID-19 vaccines, and combat the devastating impact of the pandemic.

We are highlighting a few of our clients that have driven change and are part of the reason we can see the light at the end of the COVID-19 tunnel.

As a nonprofit organization dedicated to improving the health of under-resourced communities facing systemic barriers to wellness, NHF is working with its staff and partners to ensure its recuperative care guests and community members receive their COVID-19 vaccine. NHF is also advocating for governors and state and local health authorities to prioritize people experiencing homelessness for the COVID-19 vaccine, as they are among our most vulnerable populations.

PhRMA and America’s biopharmaceutical companies came together to achieve one common goal: ending COVID-19. The industry’s shared heritage of discovery and research allowed for a swift response to the coronavirus and the development of several vaccines. Over half of PhRMA member companies have research and development efforts under way or are providing donations of medicines and critical medical supplies, as well as providing financial donations to support patients and first responders in addressing this evolving crisis. In clinical trials and collaborations with governments around the world, PhRMA members are dedicated to working together to saving lives and ensuring that COVID-19 treatments are available to patients everywhere.

As one of the country’s largest non-profit health care organizations, Providence is treating patients suffering from COVID-19 and leading vaccination roll out efforts to prevent more infection and end this pandemic. In addition, Providence committed $1.4 million to expand outreach and education, increase the COVID-19 testing and vaccination supply to marginalized communities, promote access to care and ensure equitable distribution of treatment for communities of color in Southern California.

Vivera developed a suite of lower cost COVID-19 testing, including antigen and RT-PCR diagnostic testing, that enabled businesses to create centralized site-specific protocols.  To help expand access to testing, Vivera’s philanthropic arm, Vivera Cares, launched a Matching Donation Program that committed up to $15 million of its COV-2 Rapid Tests for Tribal Nations, hospitals and their employees, health clinics, first responders, state and local governments and recognized non-profits.

Learn More

Call us today

What We Do

Our Expertise